A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)

NCT04891965 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile Infection Recurrence

Interventions

BIOLOGICAL: ART24
DRUG: Placebo

Sponsor

Adiso Therapeutics